skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Potent HIV‐1 Protease Inhibitors Containing Carboxylic and Boronic Acids: Effect on Enzyme Inhibition and Antiviral Activity and Protein‐Ligand X‐ray Structural Studies

Authors:
ORCiD logo [1];  [1];  [1];  [1];  [1];  [2];  [2];  [3];  [4];  [2];  [5]
  1. Department of Chemistry and Department of Medicinal ChemistryPurdue University West Lafayette IN 47907 USA
  2. Departments of Biology and Chemistry, Molecular Basis of DiseaseGeorgia State University Atlanta GA 30303 USA
  3. Experimental Retrovirology Section, HIV and AIDS Malignancy BranchNational Cancer Institute Bethesda MD 20892 USA; Department of Refractory Viral InfectionsNational Center for Global Heath and Medicine Research Institute Shinjuku Tokyo 162-8655 Japan
  4. Department of Refractory Viral InfectionsNational Center for Global Heath and Medicine Research Institute Shinjuku Tokyo 162-8655 Japan
  5. Departments of Hematology and Infectious DiseasesKumamoto University School of Medicine Kumamoto 860-8556 Japan; Experimental Retrovirology Section, HIV and AIDS Malignancy BranchNational Cancer Institute Bethesda MD 20892 USA; Department of Refractory Viral InfectionsNational Center for Global Heath and Medicine Research Institute Shinjuku Tokyo 162-8655 Japan
Publication Date:
Research Org.:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
UNIVERSITYNIH
OSTI Identifier:
1577162
Resource Type:
Journal Article
Journal Name:
ChemMedChem(Print)
Additional Journal Information:
Journal Volume: 14; Journal Issue: 21; Journal ID: ISSN 1860-7179
Publisher:
ChemPubSoc Europe
Country of Publication:
United States
Language:
ENGLISH

Citation Formats

Ghosh, Arun K., Xia, Zilei, Kovela, Satish, Robinson, William L., Johnson, Megan E., Kneller, Daniel W., Wang, Yuan‐Fang, Aoki, Manabu, Takamatsu, Yuki, Weber, Irene T., and Mitsuya, Hiroaki. Potent HIV‐1 Protease Inhibitors Containing Carboxylic and Boronic Acids: Effect on Enzyme Inhibition and Antiviral Activity and Protein‐Ligand X‐ray Structural Studies. United States: N. p., 2019. Web. doi:10.1002/cmdc.201900508.
Ghosh, Arun K., Xia, Zilei, Kovela, Satish, Robinson, William L., Johnson, Megan E., Kneller, Daniel W., Wang, Yuan‐Fang, Aoki, Manabu, Takamatsu, Yuki, Weber, Irene T., & Mitsuya, Hiroaki. Potent HIV‐1 Protease Inhibitors Containing Carboxylic and Boronic Acids: Effect on Enzyme Inhibition and Antiviral Activity and Protein‐Ligand X‐ray Structural Studies. United States. doi:10.1002/cmdc.201900508.
Ghosh, Arun K., Xia, Zilei, Kovela, Satish, Robinson, William L., Johnson, Megan E., Kneller, Daniel W., Wang, Yuan‐Fang, Aoki, Manabu, Takamatsu, Yuki, Weber, Irene T., and Mitsuya, Hiroaki. Fri . "Potent HIV‐1 Protease Inhibitors Containing Carboxylic and Boronic Acids: Effect on Enzyme Inhibition and Antiviral Activity and Protein‐Ligand X‐ray Structural Studies". United States. doi:10.1002/cmdc.201900508.
@article{osti_1577162,
title = {Potent HIV‐1 Protease Inhibitors Containing Carboxylic and Boronic Acids: Effect on Enzyme Inhibition and Antiviral Activity and Protein‐Ligand X‐ray Structural Studies},
author = {Ghosh, Arun K. and Xia, Zilei and Kovela, Satish and Robinson, William L. and Johnson, Megan E. and Kneller, Daniel W. and Wang, Yuan‐Fang and Aoki, Manabu and Takamatsu, Yuki and Weber, Irene T. and Mitsuya, Hiroaki},
abstractNote = {},
doi = {10.1002/cmdc.201900508},
journal = {ChemMedChem(Print)},
issn = {1860-7179},
number = 21,
volume = 14,
place = {United States},
year = {2019},
month = {9}
}

Works referenced in this record:

Tagged Hypervalent Iodine Reagents:  A New Purification Concept Based on Ion Exchange through S N 2 Substitution
journal, December 2007

  • Kunst, Eike; Gallier, Florian; Dujardin, Gilles
  • Organic Letters, Vol. 9, Issue 25
  • DOI: 10.1021/ol702319p

Design, Synthesis, Biological Evaluation, and X-ray Studies of HIV-1 Protease Inhibitors with Modified P2′ Ligands of Darunavir
journal, November 2017

  • Ghosh, Arun K.; Fyvie, W. Sean; Brindisi, Margherita
  • ChemMedChem, Vol. 12, Issue 23
  • DOI: 10.1002/cmdc.201700614

High Resolution Crystal Structures of HIV-1 Protease with a Potent Non-peptide Inhibitor (UIC-94017) Active Against Multi-drug-resistant Clinical Strains
journal, April 2004

  • Tie, Yunfeng; Boross, Peter I.; Wang, Yuan-Fang
  • Journal of Molecular Biology, Vol. 338, Issue 2
  • DOI: 10.1016/j.jmb.2004.02.052

Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS
journal, January 2016


Genotypic resistance profiles associated with virological failure to darunavir-containing regimens: a cross-sectional analysis
journal, January 2012


Refinement of Macromolecular Structures by the Maximum-Likelihood Method
journal, May 1997

  • Murshudov, G. N.; Vagin, A. A.; Dodson, E. J.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 53, Issue 3
  • DOI: 10.1107/S0907444996012255

Overview of the CCP 4 suite and current developments
journal, March 2011

  • Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4
  • DOI: 10.1107/S0907444910045749

Active human immunodeficiency virus protease is required for viral infectivity.
journal, July 1988

  • Kohl, N. E.; Emini, E. A.; Schleif, W. A.
  • Proceedings of the National Academy of Sciences, Vol. 85, Issue 13
  • DOI: 10.1073/pnas.85.13.4686

Characterization of virologic failure patients on darunavir/ritonavir in treatment-experienced patients
journal, January 2009


P-Glycoprotein Mediates Efflux Transport of Darunavir in Human Intestinal Caco-2 and ABCB1 Gene-Transfected Renal LLC-PK1 Cell Lines
journal, January 2009

  • Fujimoto, Hiromi; Higuchi, Maiko; Watanabe, Hiroshi
  • Biological & Pharmaceutical Bulletin, Vol. 32, Issue 9
  • DOI: 10.1248/bpb.32.1588

Enhancing Protein Backbone Binding-A Fruitful Concept for Combating Drug-Resistant HIV
journal, January 2012

  • Ghosh, Arun K.; Anderson, David D.; Weber, Irene T.
  • Angewandte Chemie International Edition, Vol. 51, Issue 8
  • DOI: 10.1002/anie.201102762

Sub-picomolar Inhibition of HIV-1 Protease with a Boronic Acid
journal, October 2018

  • Windsor, Ian W.; Palte, Michael J.; Lukesh, John C.
  • Journal of the American Chemical Society, Vol. 140, Issue 43
  • DOI: 10.1021/jacs.8b07366

Coot model-building tools for molecular graphics
journal, November 2004

  • Emsley, Paul; Cowtan, Kevin
  • Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132
  • DOI: 10.1107/S0907444904019158

A simple, continuous fluorometric assay for HIV protease
journal, December 1990


Features and development of Coot
journal, March 2010

  • Emsley, P.; Lohkamp, B.; Scott, W. G.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 4
  • DOI: 10.1107/S0907444910007493

Ultra-high Resolution Crystal Structure of HIV-1 Protease Mutant Reveals Two Binding Sites for Clinical Inhibitor TMC114
journal, October 2006

  • Kovalevsky, Andrey Y.; Liu, Fengling; Leshchenko, Sofiya
  • Journal of Molecular Biology, Vol. 363, Issue 1
  • DOI: 10.1016/j.jmb.2006.08.007

Design of HIV Protease Inhibitors Targeting Protein Backbone: An Effective Strategy for Combating Drug Resistance
journal, January 2008

  • Ghosh, Arun K.; Chapsal, Bruno D.; Weber, Irene T.
  • Accounts of Chemical Research, Vol. 41, Issue 1
  • DOI: 10.1021/ar7001232

Design and Development of Highly Potent HIV-1 Protease Inhibitors with a Crown-Like Oxotricyclic Core as the P2-Ligand To Combat Multidrug-Resistant HIV Variants
journal, April 2017

  • Ghosh, Arun K.; Rao, Kalapala Venkateswara; Nyalapatla, Prasanth R.
  • Journal of Medicinal Chemistry, Vol. 60, Issue 10
  • DOI: 10.1021/acs.jmedchem.7b00172

A graphical user interface to the CCP 4 program suite
journal, June 2003

  • Potterton, Elizabeth; Briggs, Peter; Turkenburg, Maria
  • Acta Crystallographica Section D Biological Crystallography, Vol. 59, Issue 7
  • DOI: 10.1107/S0907444903008126

P2′ Benzene Carboxylic Acid Moiety Is Associated with Decrease in Cellular Uptake: Evaluation of Novel Nonpeptidic HIV-1 Protease Inhibitors Containing P2 bis -Tetrahydrofuran Moiety
journal, July 2013

  • Yedidi, Ravikiran S.; Maeda, Kenji; Fyvie, W. Sean
  • Antimicrobial Agents and Chemotherapy, Vol. 57, Issue 10
  • DOI: 10.1128/AAC.00868-13

Design of Highly Potent, Dual-Acting and Central-Nervous-System-Penetrating HIV-1 Protease Inhibitors with Excellent Potency against Multidrug-Resistant HIV-1 Variants
journal, March 2018

  • Ghosh, Arun K.; Rao, Kalapala Venkateswara; Nyalapatla, Prasanth R.
  • ChemMedChem, Vol. 13, Issue 8
  • DOI: 10.1002/cmdc.201700824

Fluorine substituent effects (on bioactivity)
journal, June 2001


Oxidation of α,β-un saturated aldehydes
journal, January 1981


Verstärkung der Bindung an das Proteinrückgrat - ein fruchtbares Konzept gegen die Arzneimittelresistenz von HIV
journal, January 2012

  • Ghosh, Arun K.; Anderson, David D.; Weber, Irene T.
  • Angewandte Chemie, Vol. 124, Issue 8
  • DOI: 10.1002/ange.201102762

The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic
journal, January 2010


The Protein Data Bank
journal, January 2000


Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV
journal, December 2007

  • Ghosh, Arun K.; Dawson, Zachary L.; Mitsuya, Hiroaki
  • Bioorganic & Medicinal Chemistry, Vol. 15, Issue 24
  • DOI: 10.1016/j.bmc.2007.09.010

Structure-Based Design of Novel HIV-1 Protease Inhibitors To Combat Drug Resistance
journal, August 2006

  • Ghosh, Arun K.; Sridhar, Perali Ramu; Leshchenko, Sofiya
  • Journal of Medicinal Chemistry, Vol. 49, Issue 17
  • DOI: 10.1021/jm060561m

The mechanisms that control intracellular penetration of the HIV protease inhibitors
journal, February 2003

  • Hoggard, P. G.
  • Journal of Antimicrobial Chemotherapy, Vol. 51, Issue 3
  • DOI: 10.1093/jac/dkg137

Dimerization of HIV-1 protease occurs through two steps relating to the mechanism of protease dimerization inhibition by darunavir
journal, August 2014

  • Hayashi, H.; Takamune, N.; Nirasawa, T.
  • Proceedings of the National Academy of Sciences, Vol. 111, Issue 33
  • DOI: 10.1073/pnas.1400027111

Demonstration of Sustained Drug-Resistant Human Immunodeficiency Virus Type 1 Lineages Circulating among Treatment-Naive Individuals
journal, January 2009


INHIBITORS OF HIV-1 PROTEASE: A Major Success of Structure-Assisted Drug Design
journal, June 1998


JLigand : a graphical tool for the CCP 4 template-restraint library
journal, March 2012

  • Lebedev, Andrey A.; Young, Paul; Isupov, Michail N.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 68, Issue 4
  • DOI: 10.1107/S090744491200251X

Phaser crystallographic software
journal, July 2007

  • McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.
  • Journal of Applied Crystallography, Vol. 40, Issue 4
  • DOI: 10.1107/S0021889807021206